# Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/belantamab-mafodotin-for-relapsed-or-refractory-multiple-myeloma-dreamm-2-a-two/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Sagar Lonial,Hans C. Lee,Ashraf Badros,Suzanne Trudel,Ajay K. Nooka,Ajai Chari,Al‐Ola Abdallah,Natalie S. Callander,Nikoletta Lendvai,Douglas W. Sborov,Attaya Suvannasankha,Katja Weisel,Lionel Karlin,Edward N. Libby,Bertrand Arnulf,Thierry Façon,Cyrille Hulin,K. Martin Kortüm,Paula Rodríguez‐Otero,Saad Z. Usmani,Parameswaran Hari,Rachid Baz,Hang Quach,Philippe Moreau,Peter M. Voorhees,Ira Gupta,Axel Hoos,Eric Zhi,January Baron,Trisha Piontek,Eric Lewis,Roxanne C. Jewell,Elisha J. Dettman,Rakesh Popat,Simona Degli Esposti,Joanna Opalinska,Paul G. Richardson,Adam D. Cohen |
| Citations | 806 |
| DOI | 10.1016/s1470-2045(19)30788-0 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2995934717 |
| PMID | 31859245 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Paula Rodríguez‐Otero](https://scholariq.org/researchers/paula-rodriguez-otero/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)

## Paper topics

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Ubiquitin and proteasome pathways](https://scholariq.org/topics/ubiquitin-and-proteasome-pathways/)
- [Radiopharmaceutical Chemistry and Applications](https://scholariq.org/topics/radiopharmaceutical-chemistry-and-applications/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.